STLN

3.0005.66%
DV

Daniel Virnich

CEO & Executive Director

Dr. Daniel Virnich, also known as Dan, M.D., M.B.A., FACHE, is Chief Executive Officer of The Oncology Institute Inc. since June 2023 and serves as its Executive Director since June 13, 2024. He served as President of Starling Oncology, Inc. (formerly known as The Oncology Institute, Inc.) since March 15, 2022 until 2023. He served as Chief Operating Officer at Starling Oncology, Inc. (formerly known as The Oncology Institute, Inc.) from 2020 to March 15, 2022 and before that for Legacy TOI since 2020. Dr. Virnich served as Chief Operating Officer at Cortica Inc. since 2019. Dr. Virnich served as Market President at JSA Healthcare Corporation (Alternate Name: DaVita Medical Group) since 2018 until August 2019. Prior to this role, Dr. Virnich was a Senior Vice President of Operations in the California region with DaVita Medical Group from 2015 to 2018. Dr. Virnich previously served as the Chief Medical Officer of TeamHealth Acute Care Services, working with hospitals and healthcare systems across 26 states. He joined Starling Oncology, Inc. (formerly known as The Oncology Institute, Inc.) in 2020. Dr. Virnich served as Chief Medical Officer at Florida Hospital Medicine Services, Inc. since October 1, 2013. Dr. Virnich holds a BA in Biology from The University of Chicago, an MD from The Pritzker School of Medicine at the University of Chicago where he was elected to Alpha Omega Alpha and an MBA from Kellogg School of Management at Northwestern University.

Positions